The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
Open accessAbstract
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely used to treat malignant hematological neoplasms and non-malignant hematological disorders. Approximately, 5000 allo-HSCT procedures are performed in China annually. Substantial progress has been made in haploidentical HSCT (HID-HSCT), pre-transplantation risk stratification, and donor selection in allo-HSCT, especially after the establishment of the "Beijing Protocol" HID-HSCT system. Transplant indications for selected subgroups in low-risk leukemia or severe aplastic anemia (SAA) differ from those in the Western world. These unique systems developed by Chinese doctors may inspire the refining of global clinical practice. We reviewed the efficacy of allo-HSCT practice from available Chinese studies on behalf of the HSCT workgroup of the Chinese Society of Hematology, Chinese Medical Association and compared these studies to the consensus or guideline outside China. We summarized the consensus on routine practices of all-HSCT in China and focused on the recommendations of indications, conditioning regimen, and donor selection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
Gragert, L., Eapen, M., Williams, E., Freeman, J., Spellman, S., Baitty, R., Hartzman, R., Rizzo, J. D., Horowitz, M., Confer, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmsa1311707 · Cited by 1,103
Wang, Y., Liu, Q.-F., Xu, L.-P., Liu, K.-Y., Zhang, X.-H., Ma, X., Fan, Z.-P., Wu, D.-P., & Huang, X.-J. (2015) · Blood · doi:10.1182/blood-2015-02-627786 · Cited by 486
Self-citationOne million haemopoietic stem-cell transplants: a retrospective observational study
Gratwohl, A., Pasquini, M. C., Aljurf, M., Atsuta, Y., Baldomero, H., Foeken, L., Gratwohl, M., Bouzas, L. F., Confer, D., Frauendorfer, K., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00028-9 · Cited by 441
Huang, X.-J., Liu, D.-H., Liu, K.-Y., Xu, L.-P., Chen, H., Han, W., Chen, Y.-H., Wang, J.-Z., Gao, Z.-Y., Zhang, Y.-C., et al. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705445 · Cited by 432
Self-citationfor the European Society for Blood and Marrow Transplantation (EBMT), Passweg, J. R., Baldomero, H., Bader, P., Bonini, C., Duarte, R. F., Dufour, C., Gennery, A., Kröger, N., Kuball, J., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.34 · Cited by 395
Who is the best donor for a related HLA haplotype-mismatched transplant?
Wang, Y., Chang, Y.-J., Xu, L.-P., Liu, K.-Y., Liu, D.-H., Zhang, X.-H., Chen, H., Han, W., Chen, Y.-H., Wang, F.-R., et al. (2014) · Blood · doi:10.1182/blood-2014-03-563130 · Cited by 344
Self-citationZhu, H.-H., Zhang, X.-H., Qin, Y.-Z., Liu, D.-H., Jiang, H., Chen, H., Jiang, Q., Xu, L.-P., Lu, J., Han, W., et al. (2013) · Blood · doi:10.1182/blood-2012-11-468348 · Cited by 327
Self-citationNiederwieser, D., Baldomero, H., Szer, J., Gratwohl, M., Aljurf, M., Atsuta, Y., Bouzas, L. F., Confer, D., Greinix, H., Horowitz, M., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.18 · Cited by 311
Muffly, L., Pasquini, M. C., Martens, M., Brazauskas, R., Zhu, X., Adekola, K., Aljurf, M., Ballen, K. K., Bajel, A., Baron, F., et al. (2017) · Blood · doi:10.1182/blood-2017-03-772368 · Cited by 297
Huang, X.-J., Liu, D.-H., Liu, K.-Y., Xu, L.-P., Chen, H., Han, W., Chen, Y.-H., Zhang, X.-H., & Lu, D.-P. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.11.025 · Cited by 294
Self-citation
Cited by
Yu, S., Lin, T., Nie, D., Zhang, Y., Sun, Z., Zhang, Q., Wang, C., Xiong, M., Fan, Z., Huang, F., et al. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00591-4 · Cited by 23
Self-citation
Metadata
- Authors
- Xu, L., Chen, H., Chen, J., Han, M., Huang, H., Lai, Y., Liu, D., Liu, Q., Liu, T., Jiang, M., Ren, H., Song, Y., Sun, Z., Wang, J., Wu, D., Zhou, D., Zou, P., Liu, K., & Huang, X.
- Venue
- Journal of Hematology & Oncology
- Published
- 2018-03-02
- Volume
- 11
- Issue
- 1
- Pages
- 33-33
- ISSN
- 1756-8722 (ISSN-L)
- OpenAlex
- W2789496953
- Cited by
- 294
- References
- 30
- FWCI
- 23.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology. https://app.cochat.ai/papers/10.1186/s13045-018-0564-x
- The paper
- Xu, L., Chen, H., Chen, J., Han, M., Huang, H., Lai, Y., Liu, D., Liu, Q., Liu, T., Jiang, M., Ren, H., Song, Y., Sun, Z., Wang, J., Wu, D., Zhou, D., Zou, P., Liu, K., & Huang, X. (2018). The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-018-0564-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
